Recent News

By Category: Research

Navy Lab Refines Chem-Bio Sensor Tech

The U.S. Naval Research Laboratory announced last week it has refined a potential chemical- and biological-weapon agent scanning system to spot and characterize minuscule amounts of warfare material (see GSN, Jan. 24). Scientists headed by Joshua Caldwell and Orest Glembocki discovered that specially engineered metal nanoparticles make “surface-enhanced Raman scattering” technology 108 million times more Read More »

February 14, 2011
| Filed under North America, Countermeasures, and Research
Share

Prediction of Protein

– Protein Interactions Between Human Host and a Pathogen and its Application to Three Pathogenic Bacteria. Molecular understanding of disease processes can be accelerated if all interactions between the host and pathogen are known. The unavailability of experimental methods for large-scale detection of interactions across host and pathogen organisms hinders this process. Here we apply Read More »

February 14, 2011
| Filed under North America and Research
Share

Team Hopes To Cut Years Off Development Time Of New Antibiotics

Eliminating tens of thousands of manual lab experiments, two University of Houston (UH) professors are working toward a method to cut the development time of new antibiotics. While current practices typically last for more than a decade, a computerized modeling system being developed at UH will speed up this process…

February 14, 2011
| Filed under Research
Share

Akonni Biosystems Signs License Pact with US Army Medical Research Institute

Akonni Biosystems signs license pact with US Army Medical Research Institute …pharmabiz.comThe new markets include global bio-security, where the rapid and low-cost detection of Category A bio-threat bacterial and viral agents is critical. …

February 13, 2011
| Filed under North America, Countermeasures, and Research
Share

T cells offer new promise for vaccines for plague and bacterial pneumonias

There is currently no licensed plague vaccine in the United States, which is too bad because Yersinia pestis is arguably the most deadly bacteria known to man; most of the plague vaccine candidates that have been studied aim to stimulate B cells to produce plague-fighting antibodies, but animal studies suggest that antibodies may not be Read More »